These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32764974)

  • 41. MicroRNA-147 suppresses proliferation, invasion and migration through the AKT/mTOR signaling pathway in breast cancer.
    Zhang Y; Zhang HE; Liu Z
    Oncol Lett; 2016 Jan; 11(1):405-410. PubMed ID: 26870225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-139-3p Inhibits the Growth and Metastasis of Ovarian Cancer by Inhibiting ELAVL1 [Retraction].
    Onco Targets Ther; 2022; 15():839-840. PubMed ID: 35942189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-200b Acts as a Tumor Suppressor in Osteosarcoma via Targeting ZEB1 [Retraction].
    Onco Targets Ther; 2021; 14():4637-4638. PubMed ID: 34511931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction].
    Onco Targets Ther; 2022; 15():1317-1318. PubMed ID: 36338438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction].
    Onco Targets Ther; 2023; 16():725-726. PubMed ID: 37694105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen Receptor Beta Inhibits the Proliferation, Migration, and Angiogenesis of Gastric Cancer Cells Through Inhibiting Nuclear Factor-Kappa B Signaling [Retraction].
    Onco Targets Ther; 2020; 13():6853. PubMed ID: 32764975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Retraction].
    Onco Targets Ther; 2022; 15():757-758. PubMed ID: 35837348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα.
    Wang Y; Yin X; Zhao L; Li S; Duan J; Kuang R; Duan J
    Exp Ther Med; 2017 Aug; 14(2):1706-1714. PubMed ID: 28810639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retraction: Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 Through the Wnt Signaling Pathway.
    Pathol Oncol Res; 2021; 27():1609917. PubMed ID: 34321960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1 [Retraction].
    Am J Cancer Res; 2021; 11(6):3376. PubMed ID: 34249469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction].
    Onco Targets Ther; 2021; 14():4745-4746. PubMed ID: 34526781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():275-276. PubMed ID: 37078010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction].
    Onco Targets Ther; 2023; 16():233-234. PubMed ID: 37051318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retraction Notice to: miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo.
    Yang C; Zheng X; Ye K; Sun Y; Lu Y; Fan Q; Ge H
    Mol Ther Nucleic Acids; 2021 Dec; 26():1198. PubMed ID: 34853717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-125a Restrains Cell Migration and Invasion by Targeting STAT3 in Gastric Cancer Cells [Retraction].
    Onco Targets Ther; 2020; 13():6847. PubMed ID: 32764972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retraction: microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis
    Frontiers Editorial Office
    Front Pharmacol; 2021; 12():840009. PubMed ID: 35111073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Nrf2 Signaling Pathway in the Radiation Tolerance of Patients with Head and Neck Squamous Cell Carcinoma: An in vivo and in vitro Study [Retraction].
    Onco Targets Ther; 2022; 15():827-828. PubMed ID: 35923472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840086. PubMed ID: 35036359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
    Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
    Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.